FiercePharma’s Nick Paul Taylor writes about a new drug delivery gel developed by researchers at MIT and Brigham and Women’s Hospital. “Our system is an oil-based system gel, which makes it compatible with most drugs,” says visiting scientist Ameya Kirtane. “This enables the formulation of drugs that were not available in semi-solid or liquid dosage forms and allows patients, especially children, to more easily take their medicine.”
MIT researchers have developed a new drug-delivering gel that could make it easier for children and adults to swallow their medicine, reports Gwen Egan for Boston.com. The gel could be made in a variety of different textures and can be stored without refrigeration.
Researchers from MIT and Brigham and Women’s Hospital have developed a gel that can be mixed into medicine to make it easier to swallow, reports CBS Boston. “The gel is made out of plant-based oils and doesn’t have to be refrigerated,” says CBS Boston. “The hope is that it can one day be used to help children and adults who have trouble swallowing pills.”
InsideTracker - a personalized-nutrition company founded by scientists from MIT, Harvard, and Tufts University - utilizes blood tests to calculate biological age, reports Betsy Morris for The Wall Street Journal. The company analyzes blood samples for “markers of conditions like inflammation, heart health and liver or kidney disorder,” explains Morris. “Those who test as older than their years get recommendations to adjust diet, exercise and supplements.”
Researchers at MIT and Harvard Medical School have created an artificial intelligence program that can accurately identify a patient’s race based off medical images, reports Tony Ho Tran for The Daily Beast. “The reason we decided to release this paper is to draw attention to the importance of evaluating, auditing, and regulating medical AI,” explains Principal Research Scientist Leo Anthony Celi.
During the AI Cures Conference, Prof. Regina Barzilay spoke with Food and Drug Administration senior staff fellow Amir Khan about how the agency intends to regulate artificial intelligence in medicine, reports Casey Ross for STAT. “’My thinking is that models should be regulated based on their functionality, and not necessarily on the input data they use,” said Barzilay.
J-PAL research manager Jesse Gubb writes for STAT about how voluntary innovation tests can lead to providers favoring profitable programs over what is best for patients and can make potential reforms harder to evaluate. “The Center for Medicare and Medicaid Innovation is in the rare position of being empowered to develop innovative payment models and prospectively evaluate them,” writes Gubb. “Mandatory, national randomized evaluations ensure that the already significant effort to develop the models will yield the rigorous evidence needed to support decisions on whether to scale and adopt them broadly.”
STAT reporter Katie Palmer spotlights Principal Research Scientist Leo Anthony Celi’s research underscoring the importance of improving the diversity of datasets used to design and test clinical AI systems. “The biggest concern now is that the algorithms that we’re building are only going to benefit the population that’s contributing to the dataset,” says Celi. “And none of that will have any value to those who carry the biggest burden of disease in this country, or in the world.”
Boston Globe reporter Michael Blanding spotlights Prof. Hugh Herr’s work with Dr. Matthew Carty in developing a new amputation surgery called agonist-antagonist myoneural interface (AMI) procedure, which reconnects muscles to amplify electrical signals sent along the nerves. “My dream as a scientist is that a person with an arm amputation could play a Beethoven piece at normal speeds and dexterity – and for legs, that a person could dance ballet,” says Herr.
Professor Linda Griffith speaks with Radio Boston host Tiziana Dearing about her research on endometriosis. The dream is “that we get diagnosis at the start, and you get your therapy at the start, and you don’t even develop the disease,” says Griffith.
Researchers from MIT and journalists from STAT conducted a months long investigation and found that “subtle shifts in data fed into popular health care algorithms — used to warn caregivers of impending medical crises — can cause their accuracy to plummet over time, raising the prospect AI could do more harm than good in many hospitals,” reports Casey Ross for STAT.
PBS Nova premiered “Augmented,” a documentary film that features Prof. Hugh Herr and his research team’s work in developing brain controlled robotic limbs and reimagining amputation procedures. “Herr is teaming up with an injured climber and a surgeon at a leading Boston hospital to test a new approach to surgical amputation that allows prosthetic limbs to move and feel like the real thing,” writes PBS Nova.
Wall Street Journal reporter John Anderson spotlights “Augmented” a new PBS documentary featuring Prof. Hugh Herr and his work in robotic limbs and surgery.
A new documentary titled “Augmented” spotlights Prof. Hugh Herr and his work developing bionic limbs at the MIT Media Lab, reports Dana Gerber for The Boston Globe. “The long-term hope for the procedure is that people with Ewing amputations will be able to further adapt to the bionic limbs shown in the film, which Herr’s team is developing at MIT,” writes Gerber.
Dr. Warren Zapol ’62, an anesthesiologist at Massachusetts General Hospital who made breakthroughs in studying the impact of inhaled nitric oxide, died on Dec. 14, 2021, at the age of 79, reports Bryan Marquard for The Boston Globe. “Warren’s discovery and demonstration that nitric oxide is a highly effective therapy for pulmonary hypertension in newborns and in adults is one of the most significant achievements in recent intensive care medicine history,” says Prof. Emery N. Brown, director of the Harvard-MIT Health Sciences and Technology program.